OR WAIT 15 SECS
Hovione Technology worked with Harro Höfliger on powder filling of blisters for the reusable Papillon DPI.
Hovione Technology announced in a Nov. 19, 2019 press release that it had completed pilot-scale blister manufacturing and filling for its new reusable blister-based dry powder inhaler (DPI), the Papillon DPI, which targets affordability and environmental sustainability. The large cavity size enables filling doses of up to 50 mg and it is compatible with both carrier-based and carrier-free powder formulations.
“This is an important milestone allowing Hovione Technology to deliver Papillion inhalers together with blister samples to its pharmaceutical partners with their new inhalable powder formulations in quantities suitable for initial development purposes,” said Peter Villax, Hovione Technology’s CEO, in the press release.
“We are excited to be working with Harro Höfliger, who are experts in powder filling technologies and industrial filling machines, to establish a pilot-scale blister manufacturing solution for our Papillon DPI. We will continue to work with this partner to develop a manufacturing solution that can be smoothly integrated into standard, industrial-scale blister filling machines capable of high-volume commercial manufacturing for pharmaceutical partners,” added João Ventura Fernandes, Hovione Technology’s director of Technology Development and Licensing, in the press release.